ライフサイエンスコーパス: blindness

1 ed observational database, the Fight Retinal Blindness!

2 neration (nAMD) tracked by the Fight Retinal Blindness!

3 act perception to partial vision to complete blindness).

4 ular degeneration (AMD), is a major cause of blindness.

5 result in various phenomena of inattentional blindness.

6 Six of 14 eyes (43%) met criteria for legal blindness.

7 of their eyes to avoid vision impairment and blindness.

8 lar degeneration (AMD) is a leading cause of blindness.

9 degeneration is one of the leading causes of blindness.

10 interventions to prevent future trachomatis blindness.

11 al success, to prevent visual impairment and blindness.

12 are among the most prevalent causes of legal blindness.

13 on patients with chronic cortically-induced blindness.

14 dwide and a significant cause of preventable blindness.

15 which carries a frameshift mutation causing blindness.

16 laucoma (PACG), is a leading cause of global blindness.

17 al amaurosis (LCA16), an inherited pediatric blindness.

18 imately results in visual impairment or even blindness.

19 s for patients with severe bilateral corneal blindness.

20 by sensorineural hearing loss, dystonia and blindness.

21 ent interruptions can result in irreversible blindness.

22 t in varying degrees of vision loss and even blindness.

23 isease in immunocompromised individuals, and blindness.

24 the incidence of blindness by main cause of blindness.

25 million persons (7.7%) had presenting VI or blindness.

26 nerative disease that progresses to complete blindness.

27 ide transformative new approaches to prevent blindness.

28 the scope of cell-based therapy for corneal blindness.

29 is a leading cause of vision impairment and blindness.

30 cause they are at risk of sudden-onset legal blindness.

31 C interactions relevant for normal vision or blindness.

32 id macular edema (CME) is a leading cause of blindness.

33 uity and color vision, ultimately leading to blindness.

34 ase with severe vision impairment leading to blindness.

35 rs are the second leading cause of worldwide blindness.

36 tic patients in order to prevent unnecessary blindness.

37 es is important for prevention of DR-related blindness.

38 th PDE6 and AIPL1 can cause a severe form of blindness.

39 associated with both cataract and DR-related blindness.

40 (HSV-1), a major cause of infectious corneal blindness.

41 dney disease were associated with DR-related blindness.

42 thies," cause a range of symptoms, including blindness.

43 eceptor degeneration leading to irreversible blindness.

44 used by HSV-1 can cause corneal scarring and blindness.

45 d accounts for up to 10 percent of childhood blindness.

46 ll of excessive inflammation at the cornea - blindness.

47 or research on myosin-7a and hereditary deaf-blindness.

48 d its potential for severe VA impairment and blindness.

49 risk factor for glaucoma, a leading cause of blindness.

50 Mutations in IMPDH1 lead to inherited blindness.

51 ses are among the leading causes of acquired blindness.

52 cular trauma is critical in order to prevent blindness.

53 nd their vulnerability to disease leading to blindness.

54 eye constitute a leading cause of worldwide blindness.

55 omising visual acuity and often resulting in blindness.

56 tecedent of the current picture of childhood blindness.

57 giogenesis in the retina is a major cause of blindness.

58 form of eye diseases that cause irreversible blindness.

59 hy in its earliest stage before the onset of blindness.

60 es the risk of recurrent RRD and may lead to blindness.

61 ze rod photoreceptor cells and lead to night blindness.

62 aracterized by optic nerve aplasia and total blindness.

63 osis of a disease that can lead to permanent blindness.

64 rventional trials involving common causes of blindness.

65 in 10 eyes showed BCVA at the level of legal blindness.

66 3 dB), to unilateral (<-20 dB) and bilateral blindness.

67 e to the constitutive activity causing night blindness.

68 lls in the retina, which ultimately leads to blindness.

69 sight and retinal degenerations that lead to blindness.

70 infections are the leading cause of corneal blindness.

71 ust as it does in chronic cortically-induced blindness.

72 ES physical evaluations of presenting VI and blindness.

73 glaucoma, the leading cause of irreversible blindness.

74 d permanent ophthalmic sequelae and possible blindness.

75 ssion of almost all retinopathies leading to blindness.

76 pe 1, characterized by combined deafness and blindness.

77 on and risk for glaucoma, a leading cause of blindness.

78 on known as hemianopia or cortically-induced blindness.

79 ated to photoreceptor degeneration can cause blindness.

80 lions of children from unnecessary death and blindness.

81 nerative disease which leads to irreversible blindness.

82 nd an important cause of preventable corneal blindness.

83 e and other complications that may result in blindness.

84 ations accounting for up to 10% of childhood blindness (~1 in 5000 live birth).

85 We observe that 4 individuals with early blindness (2 females), and a group of 5 individuals with

86 as the receipt of an official certificate of blindness (a visual acuity of 3/60 or worse, or a visual

87 For river blindness, a major NTD targeted for elimination, there i

88 on deficiency (CVD), commonly called 'colour blindness', affects around 8% of men and 0.4% of women.

89 d by age and race and applied to the Prevent Blindness America eye disease prevalence values.

90 generation (AMD) is the most common cause of blindness among the elderly in the developed world.

91 ion (AMD) is a leading cause of irreversible blindness among the elderly population globally.

92 plication of diabetes and a leading cause of blindness among the working-age population.

93 ersons in the United States (7.2%) had VI or blindness, an evaluated presenting visual acuity of 20/4

94 No serious complications such as blindness, anaphylactic reaction, or terminal disease tr

95 omatis is the leading cause of noncongenital blindness and causative agent of the most common sexuall

96 delian diseases characterized by progressive blindness and caused by ultra-rare mutations.

97 ronic nature, ability to reactivate to cause blindness and encephalitis, and high prevalence in human

98 ctivation can cause severe diseases, such as blindness and encephalitis.

99 Diabetes is the leading cause of blindness and end-stage renal disease and contributes to

100 of which are used in the treatment of river blindness and other parasitic diseases.

101 immune-mediated attacks can quickly lead to blindness and paralysis if undiagnosed and untreated.

102 inflammatory disease of the CNS that causes blindness and paralysis.

103 nal degeneration 3) protein causes recessive blindness and photoreceptor degeneration in humans and i

104 mical changes can explain the dominant CORD6 blindness and recessive LCA1 blindness, both of which af

105 r degeneration (AMD) is the primary cause of blindness and severe vision loss in developed countries

106 T, was highly successful in reducing corneal blindness and severe vision-threatening complications of

107 ntly approved for the treatment of inherited blindness and spinal muscular atrophy, and long-term the

108 nstructed 73 examinees to malinger red/green blindness and subjected them to a FCT.

109 ar trauma is a major source of morbidity and blindness and the number of epidemiological studies is i

110 s a serious infection because of the risk of blindness and the occurrence of associated life-threaten

111 ccesses of VISION 2020, the burden of global blindness and vision impairment is set to reach historic

112 f diabetic retinopathy, the leading cause of blindness and vision loss in working age adults.

113 NT Despite glaucoma being a leading cause of blindness and visual impairment worldwide, no curative t

114 for postoperative outcomes and the impact on blindness and visual impairment.

115 nted with photopsias, 56% (14/25) with night blindness, and 56% (14/25) with loss of peripheral visio

116 retinal disorder (IRD) is a leading cause of blindness, and CRX is one of a number of genes reported

117 cluding stromal keratitis, corneal scarring, blindness, and encephalitis.

118 is the world's leading cause of irreversible blindness, and falls are a major public health concern i

119 a, the world's leading cause of irreversible blindness, and measured how metabolites mobilize through

120 branches, resulting in aortic arch syndrome, blindness, and stroke.

121 lectivity for auditory frequency after early blindness, and that this selectivity is maintained after

122 hicality-including ethical fading, motivated blindness, and the slippery slope-and their role in faci

123 most retinopathies that lead to irreversible blindness, and there are no effective treatments to rest

124 iabetic retinopathy (DR) is a major cause of blindness, and there is a lack of effective treatment at

125 inical manifestations, including progressive blindness, and, in mice, manifests with very early embry

126 Corneal scarring and blindness are consequences of the immune response induce

127 I 63 to 628) and 1325 (510 to 2828) years of blindness are predicted to be avoided for every 100 000

128 uality of life can be impacted negatively by blindness arising from cataract.

129 ic approaches might be effective in treating blindness arising from pathogenic variants in KCNJ13.

130 ss resulting from vision impairment (VI) and blindness as a result of uncorrected myopia and myopic m

131 e 40 years, patients proceeded to single-eye blindness as early as 19 years among those who were nona

132 se corneal scarring, ocular perforation, and blindness as early as 24 hours after birth.

133 -effectiveness ratios (ICERs) using years of blindness avoided.

134 dominant CORD6 blindness and recessive LCA1 blindness, both of which affect rods and cones, but they

135 f 130 patients with severe bilateral corneal blindness but with wet ocular surfaces.

136 nical trials for patients with hemophilia or blindness, but pre-existing neutralizing antibodies (Nab

137 s of rod and cone photoreceptors, leading to blindness, but spare downstream retinal neurons, which c

138 f visual impairment/severe visual impairment/blindness by 1.75 times (95% CI, 1.03-2.98) during this

139 700 million persons will experience MSVI or blindness by 2050, principally owing to our growing and

140 petic keratitis (HK) is the leading cause of blindness by an infectious agent in the developed world.

141 ions in intraocular pressure (IOP) can cause blindness by compromising the function of trabecular mes

142 covariates associated with the incidence of blindness by main cause of blindness.

143 tions truncating RD3 cause severe congenital blindness by preventing the inhibitory binding of RD3 to

144 Colour blindness can significantly impact quality of life for h

145 main cause for presenting and best-corrected blindness; cataract and diabetic retinopathy were the to

146 iseases linked to inflammation and inherited blindness-causing mutations in AIPL1.

147 r 2012 was cross-linked with the database of blindness certifications obtained from the National Regi

148 th Batten disease have visual impairment and blindness, cognitive and motor decline, seizures and pre

149 racterization of congenital stationary night blindness (CSNB) patients is needed for future therapeut

150 associated with congenital stationary night blindness (CSNB) results from primary deficits in the re

151 Congenital stationary night blindness (CSNB), in the complete form, is caused by dys

152 ausing recessive congenital stationary night blindness (CSNB), recessive Leber's congenital amaurosis

153 iomarkers, to counter-screen candidate river blindness cures and to interrogate the inflammatory etio

154 s a disease that initially presents as night blindness due to genetic deficits in the rod photorecept

155 s an ocular disease that causes irreversible blindness due to the degeneration of retinal ganglion ce

156 mes for wounded soldiers, often resulting in blindness due to the large variations in injury shape, s

157 eprived primary sensory areas as a result of blindness early in life.

158 uses of ulcerative mucosal sores, infectious blindness, encephalitis, and devastating neonatal diseas

159 generation (AMD) is the most common cause of blindness for individuals age 50 and above in the develo

160 ited retinal degeneration (RD) that leads to blindness for which no treatment is available.

161 ary data for causes of vision impairment and blindness form an important basis of recommendations in

162 gle-cell RNAseq data in R. dittoSeq is color blindness-friendly by default, robustly documented to po

163 data for the causes of vision impairment and blindness from 1980 to 2014.

164 ction and treatment can prevent irreversible blindness from diabetic retinopathy (DR), which is the l

165 y the global retinal community has prevented blindness from exudative and neovascular ocular diseases

166 nd one of the leading causes of irreversible blindness globally and for which intraocular pressure is

167 ped countries and is responsible for 8.7% of blindness globally.

168 indings support an account for inattentional blindness grounded in cellular biochemistry.

169 of sensory loss.SIGNIFICANCE STATEMENT Early blindness has been linked to enhanced perception of the

170 , diabetes, chronic respiratory disease, and blindness health programmes; provision of enhanced labor

171 s 1 (HSV-1) is a leading cause of infectious blindness, highlighting the need for effective vaccines.

172 Thus, after early blindness, hMT+ can exhibit selectivity for auditory fre

173 wn as incomplete congenital stationary night blindness (iCSNB), is a non-progressive inherited retina

174 fic; patients can have visual symptoms, even blindness if the branches of the ophthalmic artery are a

175 number of United States persons with VI and blindness in 2016.

176 neration (AMD) is the leading cause of legal blindness in adults 65 years of age and older.

177 The cumulative incidence of glaucoma blindness in at least 1 eye increased from 0.00 after 5

178 genital glaucoma (PCG) is a leading cause of blindness in children worldwide and is caused by develop

179 y of prematurity (ROP), the primary cause of blindness in children, is a potential complication for 7

180 of the most important preventable causes of blindness in children.

181 r degeneration (AMD) is the leading cause of blindness in developed countries, and is characterized b

182 Cataract, one of the most frequent causes of blindness in developed countries, is strongly associated

183 iple demonstrations that its mutations cause blindness in humans and dogs.

184 and RD3 truncation causes severe congenital blindness in humans and other animals.

185 ons in IPM proteoglycans are associated with blindness in humans.

186 The total prevalence of blindness in Kenya is estimated at 0.7%, however catarac

187 t contributes almost half (43%) of the total blindness in Kenya.

188 photoreceptor cell death is a major cause of blindness in many retinal dystrophies.

189 Cataract still remains the leading cause of blindness in middle-income and low-income countries.

190 role in preventing glaucoma vision loss and blindness in people of African descent living in resourc

191 nditions, and the leading cause of inherited blindness in people under the age of 60.

192 The SMR for overall blindness in people with diabetes was significantly high

193 ection, is the commonest cause of infectious blindness in the developed world.

194 ration (AMD), the most common cause of adult blindness in the developed world.

195 macular degeneration is the leading cause of blindness in the developed world.

196 eration (AMD), which is the leading cause of blindness in the elderly population of the Western hemis

197 neration (AMD), one of the leading causes of blindness in the elderly.

198 lar degeneration, is the most common form of blindness in the elderly.

199 macular degeneration (AMD), a major cause of blindness in the elderly.

200 ltifactorial disorder and a leading cause of blindness in the elderly.

201 ion (AMD), the leading cause of irreversible blindness in the elderly.

202 tor degeneration is the most common cause of blindness in the industrialized world.

203 supportive tissues can lead to irreversible blindness in the setting of age-related macular degenera

204 1 is the leading cause of infectious corneal blindness in the United States and Europe.

205 ), are among the leading causes of incurable blindness in the Western world [1].

206 , a macroparasitic disease that causes river blindness in Western Uganda and other regions of Africa.

207 iabetic retinopathy (DR) is a major cause of blindness in working adults in the industrialized world.

208 eye screening programmes, the prevalence of blindness in working-age adults is falling.

209 plication of diabetes and a leading cause of blindness in working-age adults.

210 opathy remains the leading cause of acquired blindness in working-age adults.

211 detection and treatment to prevent childhood blindness in world health organization programs.

212 f Cognitive Gadgets - to overcome "cognition blindness" in research on human evolution.

213 Mutations in this gene cause childhood blindness, in which the a- and b-wave responses of elect

214 , such as endophthalmitis, which often cause blindness is not known.

215 Recent works have shown that blindness is often associated with auditory spatial defi

216 pparently clinically inactive disease; acute blindness is rare during glucocorticoid treatment.

217 A major cause of human blindness is the death of rod photoreceptors.

218 atment of glaucoma, a major leading cause of blindness, is challenging due to poor patient compliance

219 early case identification and prevention of blindness, it is unknown in the study area, making provi

220 and neuropathy) lead to increased mortality, blindness, kidney failure and an overall decreased quali

221 Diabetes is a major cause of blindness, kidney failure, heart attacks, stroke and amp

222 d learning in patients with chronic cortical blindness, leading to recovery of motion processing in t

223 Blindness leads to substantial enhancements in many audi

224 common molecular mechanism of the childhood blindness Leber congenital amaurosis.

225 rage disorder that presents with progressive blindness, motor and cognitive decline, seizures, and pr

226 Prevalence rates of VI and blindness obtained from national survey measures varied

227 al keratitis is one of the leading causes of blindness of infected corneal diseases, but the pathogen

228 major global cause of visual impairment and blindness, often affecting marginalized populations.

229 uch less is known about the effects of early blindness on auditory cortex.

230 Here, we examine the effects of early blindness on the cortical representation of auditory fre

231 The most common conditions captured were blindness or low vision, corneal transplantation, glauco

232 lvulus, resulting in Onchocerciasis or river blindness, or Wuchereria bancrofti and Brugia malayi and

233 grees in the better eye.) Incidence rates of blindness, overall and by main cause of blindness, were

234 euritis at onset were more likely to develop blindness (P < 0.001), and those with older age of onset

235 these topics using a no-report inattentional blindness paradigm with a visual oddball sequence of geo

236 ely active species responsible for the night blindness phenotype is unclear.

237 retinal disease (IRD) characterized by night blindness, photophobia, and nystagmus, and distinctive e

238 The prevalence of blindness (presenting acuity < 3/60) among Rohingya pati

239 of <6/18 but >/=3/60 in the better eye) and blindness (presenting visual acuity of <3/60 in the bett

240 g visual acuity worse than 6/18 to 3/60) and blindness (presenting visual acuity worse than 3/60).

241 e fairly well correlated with North American blindness prevalence by condition (r(2) = 0.5898).

242 Blindness prevalence increased significantly with increa

243 We estimated VI and blindness prevalence rates and confidence intervals for

244 Interest in blindness prevention inexplicably led me to (re)pioneer

245 RetGC) isozyme RetGC1 cause various forms of blindness, ranging from rod dysfunction to rod and cone

246 Elimination of the helminth disease, river blindness, remains challenging due to ivermectin treatme

247 ced macular degeneration stage that leads to blindness, remains unknown.

248 nd 8.4 per 10 000 for overall and DR-related blindness, respectively.

249 ial productivity loss associated with VI and blindness resulting from uncorrected myopia is substanti

250 Most irreversible blindness results from retinal disease.

251 fined by World Health Organization, cortical blindness/retinal detachment, temporary facial paralysis

252 SES-related disparities in blindness risk should be explored and reduced by directi

253 2017) to highlight temporal trends in global blindness since 1990, and provide a narrative overview o

254 Monkeys with red-green colour blindness sniffed fruits more often, indicating that inc

255 myosin VIIa, can cause Usher 1B, a deafness/blindness syndrome in humans, and the shaker-1 phenotype

256 mouse model for congenital stationary night blindness that expresses the G90D rhodopsin mutant was e

257 Glaucoma is a leading cause of blindness that leads to characteristic changes in the op

258 glaucoma, a common cause of vision loss and blindness that occurs without grossly abnormal intraocul

259 ets relevant to global vision impairment and blindness that were published between 1980 and 2015.

260 evalence of functional vision impairment and blindness, the Africa Eye Foundation established the Mag

261 Thus, in cortically-induced blindness, the early post-stroke period appears characte

262 GCs are spared in several forms of inherited blindness, they are affected in Alzheimer's disease and

263 a retinal degenerative disease that leads to blindness through photoreceptor loss.

264 millions of people and is a leading cause of blindness throughout the world.

265 ity of survey self-report measures of VI and blindness to replicate results obtained through examinat

266 se of infertility and preventable infectious blindness (trachoma) in the world.

267 the effects of a congenital stationary night blindness type 2 (CSNB2)-causing mutation, I745T (IT), i

268 Core Grant P30EY019007; Research to Prevent Blindness Unrestricted Grant; Parker Family Chair; Unive

269 Self-report estimates of blindness varied between 0.1% and 5.6% for those younger

270 VI (visual acuity <20/40 to >=20/200) and blindness (visual acuity <20/200) were defined based on

271 f low vision was 14% versus 24%, and that of blindness was 3% versus 6%.

272 Blindness was defined as the receipt of an official cert

273 for VI was 11.10% (95% CI 8.1, 14.2) and for blindness was found to be 7.7% (95% CI 5.2, 10.3).

274 Unilateral blindness was noted in 18 patients (11.2%).

275 sa (adRP), which leads to loss of vision and blindness, was investigated in families lacking a molecu

276 evalence of overall vision impairment and of blindness were calculated, in addition to the most commo

277 Visual impairment, low vision, and blindness were defined according to the World Health Org

278 ultimately, societal costs of low vision and blindness were included.

279 States of America (USA) categories of VI and blindness were used.

280 s of blindness, overall and by main cause of blindness, were calculated for the years 2013-2015.

281 nsmitted disease gonorrhoea, but also causes blindness when the bacteria infect the eyes.

282 ive and leads to congenital stationary night blindness, which is generally thought to be devoid of re

283 We found no trend in VI or blindness with increasing levels of age at both 5- and 1

284 Glaucoma is a leading cause of blindness, with an estimated world-wide prevalence of 3.

285 e disease of photoreceptor cells that causes blindness within the first year of life.

286 glaucoma, the leading cause of irreversible blindness world-wide.

287 laucoma is the leading cause of irreversible blindness worldwide and requires regular monitoring upon

288 ATEMENT Glaucoma is the most common cause of blindness worldwide and, along with other optic neuropat

289 Glaucoma is a leading cause of blindness worldwide, and is characterized by progressive

290 neuropathy is a major cause of irreversible blindness worldwide, and no effective treatment is curre

291 prematurity is a leading cause of childhood blindness worldwide, but clinical diagnosis is subjectiv

292 enerations are a common cause of untreatable blindness worldwide, with retinitis pigmentosa and cone

293 glaucoma, the leading cause of irreversible blindness worldwide.

294 ophthalmic disorder and the leading cause of blindness worldwide.

295 risk factor for glaucoma, a leading cause of blindness worldwide.

296 Glaucoma is a major cause of irreversible blindness worldwide.

297 , retinitis pigmentosa are leading causes of blindness worldwide.

298 enerative diseases are the leading causes of blindness worldwide.

299 and it is the leading cause of irreversible blindness worldwide.

300 s (RGCs), is a leading cause of irreversible blindness worldwide.